S-TRAC trial: Sensitivity analyses of disease-free survival (DFS).

被引：0
|
作者：
George, Daniel J.
Pantuck, Allan J.
Motzer, Robert J.
Ravaud, Alain
Escudier, Bernard
Staehler, Michael D.
Serfass, Lucile
Krishnaswami, Sriram
Casey, Michelle
Lechuga, Mariajose
Koch, Gary
Figlin, Robert A.
机构：
[1] Duke Univ, Duke Canc Inst, Durham, NC USA
[2] Univ Calif Los Angeles, Inst Urol Oncol, David Geffen Sch Med, Los Angeles, CA USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Bordeaux Univ Hosp, Hop St Andre, Bordeaux, France
[5] Inst Gustave Roussy, Villejuif, France
[6] Ludwig Maximilians Univ Munchen, Univ Hosp Munich Grosshadern, Munich, Germany
[7] Pfizer Oncology Inc, Paris, France
[8] Pfizer, New York, NY USA
[9] Pfizer Inc, Collegeville, PA USA
[10] Pfizer Srl, Milan, Italy
[11] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[12] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.633
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
633
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Correlations between disease-free survival (DFS) and overall survival (OS) in patients (pts) with renal cell carcinoma (RCC) at high risk for recurrence: Results from S-TRAC trial
    George, D. J.
    Pantuck, A. J.
    Figlin, R.
    Escudier, B.
    Halabi, S.
    Casey, M.
    Lin, X.
    Serfass, L.
    Frean, M. J. Lechuga
    Ravaud, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 312 - 312
  • [2] Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial
    Patel, Anup
    Ravaud, Alain
    Motzer, Robert J.
    Pantuck, Allan J.
    Staehler, Michael
    Escudier, Bernard
    Martini, Jean-Francois
    Lechuga, Mariajose
    Lin, Xun
    George, Daniel J.
    CLINICAL CANCER RESEARCH, 2020, 26 (18) : 4863 - 4868
  • [3] Neutrophil-to-lymphocyte ratio as a potential prognostic factor of disease-free survival in high-risk renal cell carcinoma: Analysis of the S-TRAC trial.
    Patel, Anup
    Ravaud, Alain
    Motzer, Robert J.
    Pantuck, Allan J.
    Staehler, Michael D.
    Escudier, Bernard
    Martini, Jean-Francois
    Krishnaswami, Sriram
    Casey, Michelle
    Lechuga, Mariajose
    Lin, Xun
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Concordance between independent and investigator assessment of disease-free survival (DFS) in the APACT trial.
    Reni, Michele
    Riess, Hanno
    O'Reilly, Eileen Mary
    Reeves, James Andrew
    Chiorean, Elena
    George, Thomas J.
    Scheithauer, Werner
    Pascal, Artru
    Lerch, Markus
    Brenner, Warren S.
    Ko, Yoo-Joung
    Tabernero, Josep
    Van Cutsem, Eric
    Philip, Philip Agop
    Goldstein, David
    Berlin, Jordan
    Biankin, Andrew
    Tempero, Margaret A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] The importance of the disease-free survival (DFS) endpoint to survivors of lung cancer
    Bever, Andrea
    Manthorne, Jackie
    Rahim, Tissa
    Moumin, Layla
    Johnston, Karissa
    Szabo, Shelagh
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [6] Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study
    George, Daniel J.
    Martini, Jean-Francois
    Staehler, Michael
    Motzer, Robert J.
    Magheli, Ahmed
    Escudier, Bernard
    Gerletti, Paola
    Li, Sherry
    Casey, Michelle
    Laguerre, Brigitte
    Pandha, Hardev S.
    Pantuck, Allan J.
    Patel, Anup
    Lechuga, Maria J.
    Ravaud, Alain
    CLINICAL CANCER RESEARCH, 2018, 24 (07) : 1554 - 1561
  • [7] Disease-free survival in patients at highest risk of recurrent renal cell carcinoma in S-TRAC.
    Ravaud, Alain
    George, Daniel J.
    Motzer, Robert J.
    Pantuck, Allan J.
    Staehler, Michael D.
    Serfass, Lucile
    Krishnaswami, Sriram
    Casey, Michelle
    DeAnnuntis, Liza L.
    Lechuga, Mariajose
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Disease-free survival (DFS) in patients with triple-negative breast cancer
    Taushanova, Margarita H.
    Valev, Spartak S.
    Timcheva, Constanta V.
    ANNALS OF ONCOLOGY, 2007, 18 : 166 - 167
  • [9] Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP).
    Sweeney, Christopher
    Xie, Wanling
    Regan, Meredith M.
    Nakabayashi, Mari
    Buyse, Marc E.
    Clarke, Noel W.
    Collette, Laurence
    Dignam, James J.
    Fizazi, Karim
    Habibian, Muriel
    Halabi, Susan
    Kantoff, Philip W.
    Parulekar, Wendy R.
    Sandler, Howard M.
    Sartor, Oliver
    Soule, Howard R.
    Sydes, Matthew Robert
    Tombal, Bertrand F.
    Williams, Scott G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] ADJUVANT SUNITINIB IN PATIENTS WITH HIGH RISK RENAL CELL CARCINOMA: SUBGROUP ANALYSES FROM S-TRAC TRIAL
    Pantuck, Allan
    Patard, Jean-Jacques
    Patel, Anup
    Ravaud, Alain
    Motzer, Robert J.
    Pandha, Hardev S.
    George, Daniel J.
    Chang, Yen-Hwa
    Escudier, Bernard
    Donskov, Frede
    Magheli, Ahmed
    Carteni, Giacomo
    Laguerre, Brigitte
    Tomczak, Piotr
    Breza, Jan
    Gerletti, Paola
    Lechuga, Mariajose
    Lin, Xun
    Casey, Michelle
    Staehler, Michael
    JOURNAL OF UROLOGY, 2017, 197 (04): : E62 - E63
12345